tion. IVUS extends a measure of quality control that directs optimal balloon and stent sizing. Adjunctive IVUS use identifies suboptimal initial stent expansion and guides additional balloon angioplasty. Use of IVUS does not increase neurologic events. IVUS should be considered an important component of advanced endovascular procedures such as CAS.
Objective: Carotid artery stenting (CAS) is accepted as an alternative to carotid endarterectomy for high-risk patients with significant carotid occlusive disease. A rare complication of this approach is stent fracture. The incidence and clinical significance of carotid stent fractures are not well studied. To better understand the incidence of stent fracture and to assess whether fracture is associated with in-stent restenosis, we provide this update to our prospectively evaluated CAS patients.
Methods: Our study population includes patients who underwent CAS between January 2002 and December 2017. Patients were consented and prospectively evaluated for stent fractures by anteroposterior and lateral cervical radiographs. All fractured stents were examined by duplex ultrasound at 1 month, 6 months, and annually thereafter, with a minimum 2-year follow-up. The fracture prevalence was then calculated as a percentage of the total number of stents placed. A subset of these patients had a second radiograph 1 to 6 years after the initial radiograph to assess for late fracture development.
Results: A total of 181 patients with 206 stents have been evaluated to date, with 24 fractures identified for a fracture incidence of 11.7% during the course of our study. Of the 206 stents, 95 stents were also evaluated with a second radiograph between 1 and 6 years later, identifying 7 late stent fractures with a late fracture rate of 8.1%. Of the 24 patients with carotid stent fractures, 2 patients developed in-stent restenosis, of whom only one required reintervention.
Conclusions: Carotid artery stent fracture occurs at the rate of 11.7%. Furthermore, late stent fractures have also been identified. Currently, there is not an accepted protocol to assess for stent fractures, nor have there been morbidities identified with stent fractures. Given the significant incidence of stent fracture identified in this study, we recommend further prospective study to confirm the incidence of carotid stent fracture and to assess the relative risk of in-stent restenosis of fractured stents.
Author Disclosures: T. Carle: Nothing to disclose; N. Karani: Nothing to disclose; R. Molnar: Nothing to disclose; J. L. Williams: Nothing to disclose. Methods: From January 1996 to December 2017, there were 6636 consecutive CEAs performed. Data concerning these interventions were prospectively collected in a dedicated database. A post hoc analysis of the database was performed, and 4379 interventions performed in asymptomatic patients were found and divided in two subgroups: patients operated on between 1996 and 1999 (1321 interventions, group 1); and patients operated on between 2013 and 2017 (1179 interventions, group 2). The two groups were compared in terms of preoperative characteristics, surgery and anesthesia techniques, and perioperative results with two tests.
IP115.

Refinements in Surgical and
Results: Patients in group 2 were older than patients in group 1 and more frequently had severe cardiovascular comorbidities. There were no differences between the two groups in terms of degree of stenosis at the side operated on and status of the contralateral carotid artery. All the interventions in group 1 were performed under general anesthesia (GA) with selective shunt insertion on the basis of somatosensory evoked potential monitoring; in group 2, the corresponding figure was 14% (P < .001), whereas the remaining 1015 patients had remifentanil anesthesia with selective shunt insertion on the basis of clinical monitoring. Shunt insertion rates were 9.4% in group 1 and 13.8% in group 2 (P < .001). The frequency of primary closures fell from 39.5% in group 1 to 2.7% in group 2 (P < .001), whereas there was an increase in patch closure in group 2 (from 48% to 94%). Perioperative mortality was 0.4% in group 1 and 0.5% in group 2 (P ¼ .7), whereas perioperative stroke rate was 1% in group 1 and 0.25% in group 2 (P ¼ .01). Thirty-day stroke and death rates were 1.45% and 0.7%, respectively (P ¼ .01). The corresponding values in patients with GA without patch, with GA with patch, and with clinical monitoring with patch were 1.8%, 1.3%, and 0.5%, respectively (P ¼ 0.05). At univariate analysis, the avoidance of shunt, use of patch, and clinical monitoring significantly improved 30-day outcomes; at multivariate analysis, only the avoidance of shunt maintained its significant value (odds ratio, 4.7; 95% confidence interval, 1.7-12.8; P ¼ .002).
Conclusions: The introduction and wide diffusion in our experience of patch closure and remifentanil anesthesia with clinical monitoring allowed significant improvement of the perioperative results of CEA in the last two decades in asymptomatic patients.
Author Disclosures: A. Alessi Innocenti: Nothing to disclose; G. Bassoli: Nothing to disclose; E. Chiti: Nothing to disclose; F. Ciappi: Nothing to disclose; W. Dorigo: Nothing to disclose; F. Masciello: Nothing to disclose; C. Pratesi: Nothing to disclose; S. Speziali: Nothing to disclose. Objective: The role of the carotid plaque fibrous cap in carotid-related stroke risk has been demonstrated in many studies. The aim of this study was to evaluate the relationship between the presence of a carotid plaque ulcer and the perioperative complication risk in a consecutive series/cohort of patients submitted to carotid endarterectomy (CEA) at our academic tertiary hospital.
IP117. Perioperative Complication Risk Prediction
Methods: A retrospective review of a prospectively collected database on consecutive CEAs performed between January 2009 and December 2017 was performed. All patients with a carotid plaque ulcer (defined as a discontinuation in the carotid fibrous cap of >2 mm) at carotid duplex ultrasound were analyzed. Perioperative (30-day) complications considered for analysis were TIA, minor and major stroke, death, myocardial infarction, hemodynamic instability, cervical hematoma, and cranial nerve palsy. The prognostic value of plaque ulcer on the development of perioperative complications was assessed by odds ratio (OR) estimation.
Results: Among 964 CEAs, 158 were performed in symptomatic patients and 806 in asymptomatic patients. A carotid plaque ulcer was detected in 207 patients. Complications are reported in the Table. Plaque ulcer was significantly associated with preoperative presence of neurologic symptoms (OR, 1.51; 95% confidence interval [CI], 1.02-2.22;
